Ion exchanger treatment of citrate-stabilized plasma
US4170590A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1978 |
| Grant date | Oct 9, 1979 |
| Priority date | — |
| Expiry date | Feb 6, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A citrate-stabilized blood plasma is frozen and thawed, the undissolved cryoprecipitate is separated and is rich in factor VIII protein. The residual liquid is treated with cation and anion exchangers, either sequentially or in admixture, to separate calcium and citrate ions therefrom. The residual plasma is then subjected to adsorption to remove a fraction which is eluted and precipitated, enriched in factors II, VII, IX and X. The liquid left from adsorption is subjected to further adsorption with silicic acid, leaving a storage-stable serum. The silicic acid is eluted to dissolve adsorbed fibrinogen which then is re-precipitated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.